Work

Outcomes of additional BCG versus sequential gemcitabine + docetaxel in BCG-exposed high-risk non–muscle-invasive bladder cancer.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16600

Authors: Behzad Jazayeri, Christopher Guske, Christian Harrs, Adnan Nazir Fazili, Lexiaochuan Wen, Hongzhi Xu, Logan Zemp, Alice Yu, Scott Michael Gilbert, Michael Adam Poch, Philippe E. Spiess, Wade J. Sexton, Joshua Linscott, Roger Li

Institutions: Moffitt Cancer Center, University of South Florida

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410818451

FWCI:

Cites:

Cited by:

Related to: 10